| Literature DB >> 28216420 |
Claudia Schröder1, Niklas Thomas Baerlecken1, Ulrich Pannicke2, Thilo Dörk3, Torsten Witte1, Roland Jacobs1, Matthias Stoll1, Klaus Schwarz4, Bodo Grimbacher5, Reinhold E Schmidt1, Faranaz Atschekzei6.
Abstract
Here we describe novel mutations in recombination activation gene 1 (RAG1) in a compound heterozygous male patient with combined T and B cell immunodeficiency (CID). Clinical manifestations besides antibody deficiency included airway infections, granulomatosis and autoimmune features. He died at the age of 37 due to PML caused by JC virus infection. By targeted next-generation sequencing we detected post mortem in this patient three mutations in RAG1. One allele harbored two novel mutations (c.1123C>G, p.H375D and c.1430delC, p.F478Sfs*14), namely a missense variant and a frameshift deletion, of which the latter leads to a truncated RAG1 protein. The other allele revealed a previously described missense mutation (c.1420C>T, p.R474C, rs199474678). Functional analysis of the p.R474C variant in an in vitro V(D)J recombination assay exhibited reduced recombination activity compared to a wild-type control. Our findings suggest that mutations in RAG1, specifically the p.R474C variant, can be associated with relatively mild clinical symptoms or delayed occurrence of T cell and B cell deficiencies but may predispose to PML.Entities:
Keywords: Combined immunodeficiency (CID); Common variable immunodeficiency (CVID); Progressive multifocal leukoencephalopathy (PML); Recombination activation gene 1 (RAG1)
Mesh:
Substances:
Year: 2017 PMID: 28216420 DOI: 10.1016/j.clim.2016.12.013
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969